Trials / Sponsors / American CryoStem Corporation
American CryoStem Corporation
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection Long COVID | Phase 1 | 2023-08-01 |
| Unknown | ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion Post-Concussion Syndrome | Phase 1 | 2021-02-01 |
| Terminated | Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis Multiple Sclerosis | Phase 1 | 2014-11-01 |